The Scientific World Journal / 2013 / Article / Tab 1

Research Article

The Prevalence and Awareness of Cardiometabolic Risk Factors in Southern Chinese Population with Coronary Artery Disease

Table 1

Patients demographic stratified by gender.

VariableTotal
( )
Male
( )
Female
( )

Age (years)63.7 ± 11.462.0 ± 0.367.3 ± 0.4<0.001
Body mass index (kg/m2)23.9 ± 3.323.8 ± 0.124.1 ± 0.10.129
Systolic blood pressure (mmHg)132 ± 23131 ± 1134 ± 10.001
Diastolic blood pressure (mmHg)77 ± 1377 ± 177 ± 10.694
Total cholesterol (mmol/L)4.63 ± 1.124.48 ± 0.034.94 ± 0.04<0.001
Low-density lipoprotein cholesterol (mmol/L)2.91 ± 1.252.84 ± 0.033.06 ± 0.05<0.001
High-density lipoprotein cholesterol (mmol/L)1.06 ± 0.291.01 ± 0.011.16 ± 0.01<0.001
Triglycerides (mmol/L)1.81 ± 1.311.76 ± 0.031.91 ± 0.050.009
Lysophosphatidic acid (g/L)0.36 (0.22, 0.76)0.38 (0.22, 0.77)0.35 (0.22, 0.71)0.149
Apolipoprotein A (g/L)1.10 ± 0.281.05 ± 0.011.19 ± 0.01<0.001
Apolipoprotein B (g/L)0.78 ± 0.280.76 ± 0.010.83 ± 0.01<0.001
Fasting glucose (mmol/L)6.38 ± 2.626.26 ± 0.076.63 ± 0.100.002
Uric acid (umol/L)376 ± 113390 ± 3348 ± 4<0.001
Duration of coronary artery disease (years)
 First diagnosed patients ( )
 History diagnosed patients ( )3.00 (1.00, 8.00)2.29 (0.91, 6.66)4.45 (1.12, 10.0)<0.001
Marriage (%)89.993.881.6<0.001
Years of education (%)<0.001
 ≤961.457.269.6
 10–1220.021.816.8
 ≥1318.621.013.6
Physical activities (%)0.101
 None35.938.131.4
 ≤30 min20.920.122.6
 >30 min43.241.846.0
Smoking (%)<0.001
 Never59.041.395.4
 Past8.010.92.0
 Current32.947.72.6
Alcohol drinking (%)<0.001
 Never77.967.698.2
 Past6.910.20.4
 Current15.222.21.4
Type of coronary artery disease (%)<0.001
 Stable status41.036.550.2
 Unstable angina pectoris35.130.436.1
 Myocardial infarction23.933.113.7
Coronary artery stenosis degree of CAG<0.001
 Not conduct34.928.049.0
 <50%12.110.715.0
 50–74.9%7.98.07.8
 ≥75%45.153.328.2
Triple vessel disease (%) ( with CAG reports)51.153.543.7<0.001
Treatment of coronary disease (%)
 Percutaneous coronary intervention50.659.134.2<0.001
 Coronary artery bypass graft2.32.81.20.018
History of diseases (%)
 Hypertension56.652.863.9<0.001
 Diabetes mellitus28.325.733.6<0.001
 Dyslipidemia25.123.827.60.046
Current prevalence of diseases (%)
 Hypertension (≥140/90 mmHg for SBP/DBP or drug use)91.391.491.00.747
 Diabetes mellitus (≥7.0 mmol/L for FPG or drug use)40.939.643.30.111
 Dyslipidemia*92.093.788.9<0.001
Awareness rate of disease (%)
 Hypertension64.460.771.7<0.001
 Diabetes mellitus66.363.371.60.011
 Dyslipidemia28.526.632.70.005
The metabolic syndrome and its individual components (%)
 Defined by BMI ≥25 kg/m257.954.365.0<0.001
 Defined by BMI ≥25 kg/m2 ( with waist circumference)58.554.867.2<0.001
 Defined by waist circumference ( )66.961.280.2<0.001
 Obesity (BMI ≥25 kg/m2)34.134.533.50.647
 Obesity (waist circumference >85/80 cm for male/female)62.553.883.2<0.001
 Triglycerides (≥1.70 mmol/L)38.836.942.50.010
 High-density lipoprotein cholesterol (<1.0/1.3 mmol/L for male/female)56.550.369.1<0.001
 High blood pressure (≥130/85 mmHg for SBP/DBP)93.793.793.60.922
 Fasting plasma glucose (≥5.6 mmol/L)58.056.660.90.055

Only 1303 but not all study samples measured waist circumference. CAG: coronary angiography.
*Dyslipidemia was defined as any one of triglyceride ≥2.26 mmol/L, total cholesterol ≥6.22 mmol/L, low-density lipoprotein cholesterol ≥4.14 mmol/L, high-density lipoprotein cholesterol <1.04 mmol/L, and/or using cholesterol-lowering medicines during the last 2 weeks.

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.